NM_001963.6:c.-424G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001963.6(EGF):​c.-424G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00639 in 188,554 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0077 ( 14 hom., cov: 33)
Exomes 𝑓: 0.00069 ( 0 hom. )

Consequence

EGF
NM_001963.6 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.98

Publications

2 publications found
Variant links:
Genes affected
EGF (HGNC:3229): (epidermal growth factor) This gene encodes a member of the epidermal growth factor superfamily. The encoded preproprotein is proteolytically processed to generate the 53-amino acid epidermal growth factor peptide. This protein acts a potent mitogenic factor that plays an important role in the growth, proliferation and differentiation of numerous cell types. This protein acts by binding with high affinity to the cell surface receptor, epidermal growth factor receptor. Defects in this gene are the cause of hypomagnesemia type 4. Dysregulation of this gene has been associated with the growth and progression of certain cancers. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. [provided by RefSeq, Jan 2016]
EGF Gene-Disease associations (from GenCC):
  • familial primary hypomagnesemia with normocalciuria and normocalcemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • renal hypomagnesemia 4
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 4-109912912-G-A is Benign according to our data. Variant chr4-109912912-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 901088.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00774 (1179/152288) while in subpopulation AFR AF = 0.0268 (1114/41548). AF 95% confidence interval is 0.0255. There are 14 homozygotes in GnomAd4. There are 531 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1179 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EGFNM_001963.6 linkc.-424G>A 5_prime_UTR_variant Exon 1 of 24 ENST00000265171.10 NP_001954.2 P01133-1
EGFNM_001178130.3 linkc.-424G>A 5_prime_UTR_variant Exon 1 of 23 NP_001171601.1 P01133-3
EGFNM_001178131.3 linkc.-424G>A 5_prime_UTR_variant Exon 1 of 23 NP_001171602.1 P01133-2
EGFNM_001357021.2 linkc.-424G>A 5_prime_UTR_variant Exon 1 of 20 NP_001343950.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EGFENST00000265171.10 linkc.-424G>A 5_prime_UTR_variant Exon 1 of 24 1 NM_001963.6 ENSP00000265171.5 P01133-1
EGFENST00000509793.5 linkc.-424G>A 5_prime_UTR_variant Exon 1 of 23 2 ENSP00000424316.1 P01133-2
EGFENST00000652245.1 linkc.-424G>A 5_prime_UTR_variant Exon 1 of 20 ENSP00000498337.1 A0A494C018

Frequencies

GnomAD3 genomes
AF:
0.00774
AC:
1178
AN:
152170
Hom.:
14
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0269
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00282
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000206
Gnomad OTH
AF:
0.00383
GnomAD4 exome
AF:
0.000689
AC:
25
AN:
36266
Hom.:
0
Cov.:
0
AF XY:
0.000760
AC XY:
14
AN XY:
18416
show subpopulations
African (AFR)
AF:
0.0168
AC:
12
AN:
714
American (AMR)
AF:
0.00190
AC:
6
AN:
3156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
686
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2078
South Asian (SAS)
AF:
0.000471
AC:
2
AN:
4244
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
1480
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
102
European-Non Finnish (NFE)
AF:
0.0000458
AC:
1
AN:
21828
Other (OTH)
AF:
0.00202
AC:
4
AN:
1978
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00774
AC:
1179
AN:
152288
Hom.:
14
Cov.:
33
AF XY:
0.00713
AC XY:
531
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.0268
AC:
1114
AN:
41548
American (AMR)
AF:
0.00281
AC:
43
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000206
AC:
14
AN:
68024
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
60
120
181
241
301
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00360
Hom.:
1
Bravo
AF:
0.00884
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:1
Mar 16, 2022
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Renal hypomagnesemia 4 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
1.9
DANN
Benign
0.68
PhyloP100
-2.0
PromoterAI
-0.059
Neutral
Mutation Taster
=300/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35397046; hg19: chr4-110834068; API